This year, KWF awarded several projects from RIHS and RIMLS reseachers.
KWF has awarded a grant to Paul Span, theme Women's Cancers together with colleagues from Erasmus University Medical Center. They receive € 570.802,50 for the project: The role of APOBEC3B in breast cancer therapy resistance.KWF has awarded a grant to Mark Rijpkema, theme Urological cancers. He receives € 567.865,- for the project: Fluorescence image-guided surgery in patients with peritoneal carcinomatosis of colorectal origin.
KWF has awarded a grant to Harry Dolstra, theme Cancer development and Immune defence, and Leon Massuger, theme Women’s cancers. They receive € 987.463,20 for the project: Intraperitoneal infusion of ex vivo-generated allogeneic natural killer cells in recurrent ovarian carcinoma patients: a phase I study.
KWF has awarded a grant to Otto Boerman, theme Nanomedicine and Sandra Heskamp, theme Tumors of the digestive tract. They receive € 584.055,- for the project: Bimodal PSMA ligands for intra-operative tumor detection and photodynamic therapy of prostate cancer.
KWF has awarded a grant to Jacqueline Loonen, theme Rare cancers and coll. She receives € 438.068,20 for the project: Impaired Spermatogenesis and Testosterone Deficiency in Male Survivors of Childhood Cancer: a DCOG-LATER study.
KWF has awarded a grant to Iris Nagtegaal,. Marjolijn Ligtenberg, Nicoline Hoogerbrugge theme Tumors of the digestive tract and Jeroen van der Laak, theme Women's Cancers. They receive € 459.300,30 for the project: Identify the patient and save the family - detecting hereditary pancreatic cancer.
KWF has awarded a grant to Iris Nagtegaal, theme Tumors of the digestive tract together with colleagues from Academic Medical Center Amsterdam. They receive € 1.142.391,50 for the project: Evaluation of optimal intervals for colonoscopy surveillance: a randomized trial.
KWF has awarded a grant to Jeroen van der Laak, theme Women's Cancers. together with colleagues from Leiden University Medical Center. They receive € 625.627,70 for the project: Chemotherapy or not? Practice changing approach for the selection of patients for accurate chemotherapy treatment after colon cancer diagnosis.
KWF has awarded a grant to Frank van Leeuwen, theme Cancer development and Immune defence. He receives € 490.879,60 for the project: Breaking therapy resistance in IKZF1 deleted Acute Lymphoblastic Leukemia.
KWF has awarded a grant to Peter Siersema, theme Tumors of the digestive tract together with colleagues from Maastricht University Medical Center. They receive €399.418,90 for the project: Standardizing trAining for endoscopic resection of large non-pedunculated colorectal polyps: It is prime-time to change practice.
KWF has awarded a grant to John Hermans, theme Rare cancers. He receives € 692.147,95 for the project: Diagnostic accuracy of contrast enhanced diffusion weighted MRI for liver metastases of pancreatic cancer: towards adequate staging of pancreatic cancer
KWF has awarded a grant to Angela Maas, theme Vascular damage together with colleagues from the Netherlands Cancer Institute. They receive € 791.175,10 for the project: Favorable and unfavorable effects of risk-reducing salpingo-oophorectomy (RRSO) in women at high genetic risk of ovarian cancer.
KWF has awarded a Young Investigators Grant (€ 656.250,-) to Sandra Heskamp, theme Tumors of the digestive tract for her project: Towards personalized use of immune checkpoint inhibitors by imaging of the PD-1/PD-L1 pathway.
KWF has awarded a Young Investigators Grant (€ 601.250,-) to Willemijn Hobo, theme Cancer development and Immune defence for her project: Boosting graft-versus-leukemia immunity by combining hypomethylating angents and immunotherapy in patients with acute myeloid leukemia.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Nijmegen researchers find new genetic cause bubble boy disease SCID Genetic new born screening SCID can be further refined
19 March 2024Researchers from Nijmegen and Newcastle discovered a new genetic mutation leading to severe combined immune deficiency disorder (SCID). It’s the first time a mutation in the proteasome, a molecular shredder, has been linked to this serious disease.
read moreOnePlanet Research Center celebrates five-year anniversary with event 'Gelderland innovations with global impact'
7 March 2024The OnePlanet Research Center innovation center is five years old and is celebrating with an anniversary event on April 3, 2024 at Industriepark Kleefse Waard in Arnhem.
read more